Mph health care

What Mph health care does

MPH Health Care AG is a Berlin-based, publicly listed investment holding company (Frankfurt Stock Exchange Open Market, ISIN: DE000A289V03, ticker 93M1) founded in 2008 and operating since its 2009 IPO. The company pursues long-term equity investments in the growth segments of the healthcare market — specifically chronic diseases, medical aesthetics, and digitalisation — together with selective adjacent high-growth sectors including renewable energy and affordable housing. Its portfolio comprises three listed operating companies: M1 Kliniken AG (market-leading German aesthetic medicine provider with operations in 7 countries; FY2025 consolidated revenue EUR 364.3M), HAEMATO AG (pharmaceutical distribution focused on oncology, HIV, and chronic diseases, with HAEMATO PHARM GmbH divested to PHOENIX group on 31 January 2026), and CR Capital AG (renewable energy and affordable housing). MPH also holds non-listed healthcare investments via MPH Ventures GmbH and Pharmigon GmbH.

The company's revenue model is non-operational: MPH generates no direct product or service revenue. Financial performance is driven entirely by fair value measurement of its listed portfolio investments (recognised through profit and loss under IFRS), dividend income from holdings, and capital gains/losses on disposals. FY2024 reported net profit of EUR 32.0M was followed by a FY2025 net loss of EUR 29.3M, primarily due to a non-cash fair value write-down following the insolvency of CR Energy AG (formerly part of CR Capital AG). NAV declined from EUR 277.9M (end-2024) to EUR 191.4M (Q1-2026), while equity ratio remained exceptionally high at 91.9%. MPH's go-to-market approach is investor-relations-driven: equity distribution via Xetra, regional German exchanges, and Tradegate, supported by designated sponsors (ODDO BHF, MWB Fairtrade), EQS/DGAP news distribution, analyst coverage (First Berlin, GBC Research), and an annual shareholder meeting in Berlin. Shareholder structure is anchored by Apomone Verwaltung GmbH (44%) with 56% free float.

Name

Mph health care

Legal name

MPH Health Care AG

Website

https://mph-ag.de

Company type

Public

Founded year

2008

Operating status

Operating

Headcount range

1–10 employees

Short description

MPH Health Care AG is a Berlin-based, publicly listed investment holding company that acquires and develops long-term stakes in growth segments of the healthcare market (aesthetics, chronic diseases, digitalisation) and adjacent sectors, primarily serving equity investors via Frankfurt Stock Exchange listings and dividend distribution.

Ownership category

akta.pro rank

Product category

Investment Holding / Asset Management

NAICS

Funds, Trusts, and Other Financial Vehicles (525), Portfolio Management and Investment Advice (523940)

SIC

Security Brokers, Dealers & Flotation Companies (6211)

akta.pro primary industry

Healthcare & Life Sciences Growth Equity (FSANACAB)

Keywords

• Healthcare investment holding
• Asset management services
• Medical aesthetics investment
• Pharmaceutical distribution holdings
• Venture capital healthcare

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Investment Returns and Fair Value Appreciation: MPH measures its listed investments (M1 Kliniken AG, CR Capital AG, HAEMATO AG) at fair value through profit or loss. Increases in fair value of portfolio company share prices drive net profits; decreases drive losses. This is the primary source of IFRS net profit/loss reported each period. Revenue is non-cash and valuation-dependent.
2. Dividend Income from Portfolio Companies: MPH receives dividends from its listed holdings, notably M1 Kliniken AG. The company passes through value to shareholders through an attractive dividend policy. Dividend per share proposed at EUR 5.00 for FY2025 (approved July 2026 AGM), up from EUR 1.20 in prior years.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

MPH Health Care AG is a listed investment holding company that acquires, develops, and holds long-term stakes in companies operating in growth segments of the healthcare market — particularly medical aesthetics, chronic diseases (oncology, HIV), and healthcare digitalisation — alongside select adjacent sectors such as real estate and renewable energy. The company provides shareholders with access to healthcare market growth through dividend pass-through and NAV appreciation of its listed portfolio companies, primarily M1 Kliniken AG, HAEMATO AG, and CR Capital AG.

Product overview

MPH Health Care AG is an investment holding company that operates as a unified investment platform with multiple portfolio companies. The core investment management services coordinate and develop portfolio holdings including M1 Kliniken AG (aesthetic medicine), HAEMATO AG (pharmaceuticals), CR Capital AG (real estate/energy), and a Ventures division for non-listed healthcare investments. The company pursues long-term value creation through active portfolio management and strategic development of holdings.

Differentiator

Problem solved

Functional benefit

Products and services

• Investment Management Services Long-term investment strategy and active portfolio management focused on healthcare market growth segments around medical aesthetics, chronic diseases, and healthcare digitalisation, plus selected adjacent high-growth sectors such as real estate and renewable energy. Provided to equity investors and shareholders of MPH Health Care AG.
• M1 Kliniken AG (portfolio holding) Leading private provider of aesthetic and plastic beauty medicine services in Germany with international expansion to 6 other countries. Operates specialist medical centres offering minimally invasive and surgical procedures and outpatient medical specialist centres. Held as a core listed portfolio company of MPH Health Care AG.
• MPH Ventures Portfolio Non-listed investments in the healthcare market, including cytostatic solutions preparation, accompanying medications, and incubation of innovative healthcare start-ups. Managed through MPH Ventures GmbH.

Quantifiable outcome

• Equity ratio consistently above 90% (94.3% at FY2025, 91.9% at Q1-2026), reflecting extremely strong balance sheet
• +4 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

Partnerships

Six partnerships are on record, tiered minor, core and secondary.

• HAEMATO AGminorStrategic or Co-development Partner · 1 January 2020HAEMATO AG was sold by MPH to M1 Kliniken AG on 1 July 2020 as part of a strategic restructuring. HAEMATO AG specialises in the import and distribution of COVID diagnostics and low-priced EU/original pharmaceuticals (generics, parallel imports, re-imports) with a focus on oncology, HIV, and other chronic diseases. Listed on Frankfurt Stock Exchange (Open Market, ISIN: DE000A289VV1). M1 Kliniken AG (85%-owned via Haemato AG subsidiary) sold HAEMATO PHARM GmbH to PHOENIX group on 31 January 2026.
• M1 Med Beauty Berlin GmbHminorOthers · 1 January 2020M1 Med Beauty Berlin GmbH provides operational services to MPH Health Care AG including email server hosting (protected and secured), telephone reporting server administration, and video surveillance administration of business premises. This is an intra-group service relationship.
• M1 Kliniken AGcoreStrategic or Co-development Partner · 1 January 2015M1 Kliniken AG is MPH Health Care AG's core listed investment and key value driver. Specialises in aesthetic and plastic beauty medicine, is the market leader in Germany, and operates internationally in 6 countries beyond Germany (as of 2019 expansion). MPH holds a significant equity stake. M1 Kliniken AG is listed on Frankfurt Stock Exchange (Open Market, ISIN: DE000A0STSQ8). The company operates specialist medical centres offering minimally invasive and surgical aesthetic treatments and outpatient medical specialist centres.
• CR Capital AGsecondaryStrategic or Co-development Partner · 1 January 2014CR Capital AG is a listed investment company (Frankfurt Stock Exchange Open Market, ISIN: DE000A2GS625) focused on innovative companies in renewable energy and affordable housing. MPH holds a direct stake. CR Capital supports Solartec (smart energy supply for residential neighbourhoods) and Terrabau (affordable housing construction). CR Opportunities launches high-yield investments. CR Energy AG filed for insolvency in June 2025 (proceedings opened 1 September 2025), significantly impacting MPH's 2025 financials.
• EQS Group AGminorOthersEQS Group AG (Karlstraße 47, 80333 Munich, owner of dgap.de) provides newsletter distribution and IR communication services to MPH Health Care AG. Used for sending corporate news and ad-hoc announcements to subscribed investors.
• Link Market Services GmbHminorOthersLink Market Services GmbH (Landshuter Allee 10, 80637 Munich) is commissioned by MPH to handle the proceedings of the Annual General Meeting, including attendance verification, technical infrastructure for voting, and documentation. Bound by data processing agreement under Art. 28 DSGVO.

Scale indicators18 records

Recent moves10 records

Expansion highlights5 records

Broad incumbents

• Partners Group: Global private markets firm with healthcare growth and buyout strategies. Comparable to MPH in the sense of pursuing long-term, active investments in healthcare growth themes, though operating at much larger scale and with private fund vehicles.
• Kinnevik AB: Swedish-listed investment company with significant healthcare exposure (including telehealth and care providers). Comparable to MPH as a publicly listed, long-term-focused investment vehicle with healthcare as a core growth theme.
• Ares Management - Healthcare Strategy: Global alternative asset manager with dedicated healthcare private equity strategies. Comparable to MPH as a healthcare-focused investment manager, though at significantly larger scale and with private (not listed) fund structures.

Direct peers

• Deutsche Beteiligungs AG: Frankfurt-listed private equity company that invests in mid-market German companies. Comparable to MPH as a publicly traded German investment company pursuing long-term value creation through portfolio company development, though with a broader sector focus than MPH's healthcare concentration.
• BB Biotech AG: Swiss-listed investment company focused on biotechnology and healthcare equities. Comparable to MPH as a publicly traded investment vehicle providing investors liquid exposure to healthcare growth via a portfolio of listed holdings.
• M1 Kliniken AG: MPH's core portfolio company, a Frankfurt-listed aesthetic medicine provider. Comparable as a healthcare growth equity exposure within MPH's portfolio and as a separately listed peer for investors evaluating MPH's underlying value.
• Aurelius AG: Munich-listed investment holding company that acquires and develops companies across multiple sectors. Closely comparable to MPH as a German mid-cap listed investment vehicle with active portfolio management and a focus on value creation through operational improvements.
• HAEMATO AG: Frankfurt-listed pharmaceutical company specializing in generics, parallel imports, and chronic disease therapeutics, originally an MPH investment. Comparable as a separately listed healthcare holding within the MPH ecosystem.

Emerging players

• Gurnet Point Capital: Boston-based healthcare-focused investment firm with concentrated long-term holdings in pharma and life sciences. Comparable to MPH in pursuing concentrated, long-duration healthcare growth investments, though at a different scale and geography.

Regional players

• Cobham Capital: European healthcare and life sciences investment firm. Comparable to MPH as a sector-focused investor in healthcare growth themes in Europe, though operating via private fund structures rather than as a listed holding company.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mph health care